The Cannigma

MAY 19, 2021

While many countries around the world have legalized or decriminalized cannabis or have eased up on enforcement in recent years, in Japan in 2018 there was a sharp increase in cannabis-related arrests — and 80% of them were possession charges. of Japanese have reported consuming cannabis, as opposed to more than 40% in the US and Canada.

Law 145

Law Legalization Clinical Trials CBD 145

The Cannigma

MARCH 18, 2021

Any future research or clinical trials targeting the efficacy of cannabis should clearly define these recommendations for use and prioritize the communication of such recommendations to enrolled participants,” they added.

Patients 145

Patients Clinical Trials Treatment Cannabis 145

The Cannigma

JUNE 23, 2022

While CBG (cannabigerol) has been hailed ‘the mother of all cannabinoids,’ it’s time to reveal the true heir to the throne – cannabigerolic acid, or CBGA. This cannabinoid has only recently been studied, and future studies will certainly divulge its exact importance. What is the difference between CBG and CBGa? What does CBGA do?

Cannabinoids 126

Cannabinoids Research and Development Clinical Trials Extraction 126

Cannabis Law Report

AUGUST 10, 2021

This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. Cannvalate was established in early 2018 by co-founders Sud Agarwal, Asaf Katz and Darryl Davies. billion in 2030. About Cannvalate.

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

The Cannigma

DECEMBER 14, 2021

Hexahydrocannabinol (HHC), which was patented in the late 1940s as a “therapeutic substance having marihuana activity,” is a cannabinoid that’s growing in popularity and availability. Hydrogenation of THC isomers such as delta-9-THC or delta-8-THC results in the formation of hexahydrocannabinol (HHC), a hydrogenated cannabinoid.

Research and Development 116

Research and Development Clinical Trials Cannabinoids THC 116

MedicalJane

OCTOBER 3, 2019

The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical trial at the Montefiore Medical Center in New York. The study examines the effect of the cannabinoid Cannabidivarin, more commonly referred to as CBDV , on irritability and repetitive behaviors in children with autism spectrum disorder.

Clinical Trials 74

Clinical Trials Epilepsy Pharmaceutical Treatment 74

The Cannigma

MAY 6, 2021

Along with delta-9-THC, delta-8 is one of the few cannabinoids considered to be intoxicating. (El The cannabis plant can produce a great number of active compounds — those unique to cannabis are called cannabinoids. Interestingly, along with delta-9-THC, delta-8 is one of the few cannabinoids considered to be intoxicating.

THC 145

THC Cannabinoids Concentrates Hemp 145

Miss Marijuana

FEBRUARY 7, 2025

Understanding Cannabinoids: The Basics of CBD and THC Cannabinoids, CBD, THC—chances are you’ve heard these terms buzzing around lately, and for good reason! Cannabinoids are typically extracted from cannabis plants through a variety of methods. Once extracted, these cannabinoids interact with your body’s endocannabinoid system.

THC 52

THC CBD Chronic Pain Cannabinoids 52

Cannabis Law Report

JANUARY 3, 2022

(Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, announces that the first patient has been dosed in a Phase 2 proof-of-concept clinical study investigating ANEB-001 as a potential treatment for acute cannabinoid intoxication.

Pharmaceutical 52

Pharmaceutical Cannabinoids Treatment Clinical Trials 52

MedicalJane

MAY 21, 2020

Animal studies are not only valuable, they can also be superior to clinical trials in some cases because they can circumvent human biases and expectancy effects, or perceptual and cognitive reactions to participation in cannabis-based experiments. The Hemp Farming Act of 2018. percent on a dry weight basis.”.

Oil 100

Oil Hemp Extraction Clinical Trials 100

Otherside Farms

JULY 8, 2020

With over 100 potent cannabinoids that constitute the Cannabis plant, the possibilities of health benefits are ample. The healthcare industry is seeing significant investments in clinical trials to prove the health benefits of cannabis. The presence of cannabinoids can reduce muscle ache and ease inflammation.

Marijuana 105

Marijuana Sleep Clinical Trials Events 105

CannaMD

AUGUST 8, 2020

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. However, many of these products contain a number of other cannabinoids as well. To understand cannabinoids, we need to take a closer look at the endocannabinoid system. More recently, the 2018 Farm Bill expanded hemp legislation.

CBD 105

CBD DEA Research and Development Hemp 105

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. However, because cannabinoids reduce seizures through numerous mechanisms of actions, possible drug interactions are still unclear. References Staff, T.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Project CBD

FEBRUARY 28, 2023

sativa do not naturally contain cannabinoids, but they can become contaminated with CBD from other plant parts during processing. 13 Although many review authors reported inconclusive findings due to low-quality studies, they noted that evidence from human clinical trials seems to support CBD’s positive effects on nociceptive pain (i.e.,

CBD 144

CBD Seed-To-Sale Food Access 144

CannaMD

NOVEMBER 15, 2020

research scene is also dominated by research on the harmful effects of cannabis, but Canada has dedicated much more funding to positive cannabinoid research. In Canada, recreational marijuana use was legalized in October 2018. Department of Defense has spent several million dollars on cannabinoid research.

DEA 105

DEA Clinical Trials Cannabinoids Treatment 105

Puff Puff Post

OCTOBER 3, 2019

Previous success from treating epilepsy with Cannabinoids now motivates doctors to investigate the plant’s effectiveness in treating symptoms of autism. The possibility of treating the symptoms associated with autism originated when the FDA approved Epidoliolex in 2018.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

The Cannigma

AUGUST 14, 2022

There is certainly some evidence that cannabis may be helpful with increasing focus, in the right dose with the right terpenes and cannabinoids. The short answer is maybe – it depends on several factors, including the cannabinoids and terpenes in your weed, as well as how much you consume. It starts with the right cannabinoids.

Terpenes 128

Terpenes Strains THC Oil 128

Canna Care Docs

DECEMBER 11, 2018

. “Americans Who Smoke Marijuana By Age Group 2017 | Statistic” 2018. Accessed December 5 2018. “Cannabis And Pain: A Clinical Review” Cannabis And Cannabinoid Research 2 (1): 96-104. Accessed December 5 2018. O’Neill, Stephanie. Hill, Kevin P., Mary Ann Liebert Inc. Russo, Ethan B.,

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

Cannabis Law Report

SEPTEMBER 22, 2021

Oxford Cannabinoid Technologies Holdings plc. . Access to Canopy Growth’s cannabinoid library including 335 derivatives and 14 patent families. Accelerated timelines to clinical trials and expansion of drug development pipeline. Phase 1 clinical trials are scheduled for Q3 2022 with Phase 2 trials expected in Q2 2023.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Cannabinoids 52

LifeCannMD

MAY 27, 2025

2018, when the FDA approved Epidiolexthe first cannabis medication ever approved in the United States. I had one parent describe it perfectly: “It’s like CBD taught my daughter’s brain how to use its brakes again.” ” When the FDA Finally Caught Up You know what really legitimized all this for me?

CBD 52

CBD Oil Epilepsy Conditions 52

Cannabis Law Report

JANUARY 14, 2022

Right-to-try aims to allow patients who have been diagnosed with life-threatening diseases or conditions who have tried all approved treatment options and who are unable to participate in a clinical trial to access certain unapproved treatments. Right-to-try permits those patients to have access to investigational drugs.

Treatment 52

Treatment Access Clinical Trials Patients 52

MedicalJane

JUNE 29, 2018

Food and Drug Administration (FDA) had approved only three cannabinoid-based medicines. On June 26, 2018, the FDA granted approval of Epidiolex, a cannabidiol (CBD) oral solution, to GW Research Ltd (GW). percent of tetrahydrocannabinol (THC), the cannabinoid responsible for producing “high” psychoactive effects when consumed.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

After securing FDA approval in June of 2018, Epidiolex’s manufacturer GW Pharma announced the drug should enter the consumer market by the end of 2018. GW Pharma carefully developed Epidiolex using cannabinoids to reduce the occurrence of seizures. Cannabis Legalization Throughout The Country.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

CannaMD

NOVEMBER 8, 2019

At present, most products containing THC, CBD, or other cannabinoids are not approved for this purpose by the FDA. In fact, we know very well that people with PTSD who use marijuana — a potent cannabinoid — often experience more relief from their symptoms than they do from antidepressants and other psychiatric medications.

Marijuana 85

Marijuana Treatment Research and Development Patients 85

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Since cannabinoids, including CBD, share metabolic pathways with other drugs, and have similar mechanisms of action with other drugs, the potential for interaction exists.

CBD 98

CBD THC Conditions Medicine 98

CannaMD

AUGUST 26, 2020

A new review published by scientific journal, Pharmacology Biochemistry and Behavior , has found that marijuana cannabinoid, CBD, is a “promising” therapy for treating cocaine dependence. Exploring alternative therapies, researchers turned their attention to marijuana cannabinoid, cannabidiol – more commonly referred to as CBD.

Therapy 98

Therapy CBD Research and Development Treatment 98

SpeedWeed

DECEMBER 28, 2018

In my defense, 2018 has been a wild ride in the world of weed, a 12-month timespan which truly could be called “the best of times and the worst of times,” or perhaps just the highest and lowest of times. The Top 10 Cannabis Stories of 2018. But until then, here are the buzzes and bummers 2018 had to offer.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Cannabis Law Report

JANUARY 4, 2022

Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, has named Simon Allen as Chief Executive Officer and a member of the company’s Board of Directors, effective February 1 st , 2022. Anebulo Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Cannabinoids 52

Cannabis Info

OCTOBER 11, 2019

In the Australian clinical study, cannabinoids will be extracted and delivered in a mouth spray, making it easier to be administered to the elderly. The clinical trial will be held over a 14-month period starting early next year. But it is significant that the clinical trials are taking place overseas.

Treatment 45

Treatment Clinical Trials Cannabinoids Cannabis 45

Cannabis Law Report

JUNE 15, 2022

Materia is one of many other operators that have recently established a headquarters in Malta since the legislation permitting the production of medical cannabis products for research and medical purposes was enacted in 2018. Clinical trials, etc.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Packaging 52

LifeCannMD

AUGUST 23, 2021

CBD is a common cannabinoid that does not have psychoactive properties as it does not contain THC. All of which are available in our online store and our Miami Medical Marijuana Clinic. Most clinical trials have involved doses between 25 to 1,500 mg. CBD also doesn’t lead to any potential dependence or abuse.

CBD 52

CBD Sleep Clinical Trials Cannabinoids 52

Otherside Farms

NOVEMBER 3, 2019

The “entourage effect” is the latest buzz in cannabis media, presenting a well-formed scientific hypothesis that cannabinoids don’t just work on their own. They work in tandem with a bunch of other cannabinoids, terpenoids, and flavonoids. It is a non-psychoactive cannabinoid that modulates the effect of psychoactive THC.

Terpenes 58

Terpenes CBD Research and Development Cannabinoids 58

Cannabis Law Report

AUGUST 26, 2019

The review found that marijuana, or products having cannabinoids are effective at relieving chronic pain. The comprehensive review of the evidence, published in the journal of Clinical Psychology Review , exposed that using marijuana helps people with alcohol or opioid dependencies to fight against their addictions.

Chronic Pain 45

Chronic Pain Clinical Trials Epilepsy Conditions 45

Cannabis Law Report

MARCH 21, 2019

All cannabis plants contain cannabinoids, which are a group of similar compounds. The industrial hemp plant happens to contain large quantities of special cannabinoids known as cannabidiol or CBD for short. In 2018, Kansas passed the Senate Bill 282 allowing any adult to legally purchase CBD as long as the product contains 0% THC.

State Laws 55

State Laws Law CBD Legalization 55

Cannabis Law Report

MARCH 2, 2020

The move follows the law change in October 2018 to allow specialist doctors to prescribe cannabis-based products for medicinal use where clinically appropriate in the UK, which has been condemned within the UK’s cannabis sector.

Medicine 45

Medicine Research and Development Clinical Trials Patients 45

Cannabis Law Report

NOVEMBER 1, 2021

Cannabis, THC and certain cannabinoids are psychoactive and have potential for abuse, resulting in drug dependence and harm to the health of users. Since March 2019, Customs and Excise Department officers detected 10 cases in which a total of 194 imported CBD products were found to have traces of THC.

Wellness and Beauty 52

Wellness and Beauty CBD Clinical Trials Pharmaceutical 52